CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth-Reference-Cited by-同舟云学术

CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth

Author:

Inoue Hiromi¹²,Kauffman Michael³,Shacham Sharon³,Landesman Yosef³,Yang Joy⁴,Evans Christopher P.⁴⁵,Weiss Robert H.¹²⁵⁶

Affiliation:

1. Division of Nephrology, Department of Internal Medicine, University of California-Davis, Davis, California

2. Comparative Pathology Graduate Group, University of California-Davis, Davis, California

3. Karyopharm Therapeutics, Inc., Natick, Massachusetts

4. Department of Urology, University of California-Davis, Davis, California

5. Cancer Center, University of California-Davis, Davis, California

6. Medical Service, Sacramento Veterans Affairs Medical Center, Sacramento, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference29 articles.

1. Renal cell carcinoma;Cairns;Cancer Biomark,2010

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Nuclear Transport Inhibitors;Therapeutic Strategies in Veterinary Oncology;2023-08-23